title: Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones.
abstract: Chagas disease (CD), caused by Trypanosoma cruzi, affects approximately eight million individuals in Latin America and is emerging in nonendemic areas due to the globalisation of immigration and nonvectorial transmission routes. Although CD represents an important public health problem, resulting in high morbidity and considerable mortality rates, few investments have been allocated towards developing novel anti-T. cruzi agents. The available therapy for CD is based on two nitro derivatives (benznidazole (Bz) and nifurtimox (Nf)) developed more than four decades ago. Both are far from ideal due to substantial secondary side effects, limited efficacy against different parasite isolates, long-term therapy, and their well-known poor activity in the late chronic phase. These drawbacks justify the urgent need to identify better drugs to treat chagasic patients. Although several classes of natural and synthetic compounds have been reported to act in vitro and in vivo on T. cruzi, since the introduction of Bz and Nf, only a few drugs, such as allopurinol and a few sterol inhibitors, have moved to clinical trials. This reflects, at least in part, the absence of well-established universal protocols to screen and compare drug activity. In addition, a large number of in vitro studies have been conducted using only epimastigotes and trypomastigotes instead of evaluating compounds' activities against intracellular amastigotes, which are the reproductive forms in the vertebrate host and are thus an important determinant in the selection and identification of effective compounds for further in vivo analysis. In addition, due to pharmacokinetics and absorption, distribution, metabolism, and excretion characteristics, several compounds that were promising in vitro have not been as effective as Nf or Bz in animal models of T. cruzi infection. In the last two decades, our team has collaborated with different medicinal chemistry groups to develop preclinical studies for CD and investigate the in vitro and in vivo efficacy, toxicity, selectivity, and parasite targets of different classes of natural and synthetic compounds. Some of these results will be briefly presented, focusing primarily on diamidines and related compounds and naphthoquinone derivatives that showed the most promising efficacy against T. cruzi.
authors.affiliation: Laboratório de Biologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, 21040-900 Rio de Janeiro, RJ, Brazil.
authors.forename: Solange L
authors.initials: SL
authors.lastname: de Castro
authors.forename: Denise G J
authors.initials: DG
authors.lastname: Batista
authors.forename: Marcos M
authors.initials: MM
authors.lastname: Batista
authors.forename: Wanderson
authors.initials: W
authors.lastname: Batista
authors.forename: Anissa
authors.initials: A
authors.lastname: Daliry
authors.forename: Elen M
authors.initials: EM
authors.lastname: de Souza
authors.forename: Rubem F S
authors.initials: RF
authors.lastname: Menna-Barreto
authors.forename: Gabriel M
authors.initials: GM
authors.lastname: Oliveira
authors.forename: Kelly
authors.initials: K
authors.lastname: Salomão
authors.forename: Cristiane F
authors.initials: CF
authors.lastname: Silva
authors.forename: Patricia B
authors.initials: PB
authors.lastname: Silva
authors.forename: Maria de Nazaré C
authors.initials: Mde N
authors.lastname: Soeiro
references.citation: Biochimie. 2008 Jul;90(7):999-1014
references.pmid: 18343228
references.citation: J Antimicrob Chemother. 2006 Sep;58(3):610-4
references.pmid: 16854954
references.citation: Biochem Pharmacol. 2004 Aug 15;68(4):593-600
references.pmid: 15276066
references.citation: Chem Res Toxicol. 2000 Mar;13(3):135-60
references.pmid: 10725110
references.citation: Trans R Soc Trop Med Hyg. 1987;81(5):755-9
references.pmid: 3130683
references.citation: Am Heart J. 2008 Jul;156(1):37-43
references.pmid: 18585495
references.citation: Nature. 2010 Jun 24;465(7301):S12-5
references.pmid: 20571548
references.citation: Drug Des Devel Ther. 2010 Sep 24;4:243-53
references.pmid: 20957215
references.citation: Mini Rev Med Chem. 2004 Jan;4(1):23-30
references.pmid: 14754440
references.citation: Free Radic Biol Med. 1989;7(4):435-77
references.pmid: 2691341
references.citation: J Antimicrob Chemother. 2009 Oct;64(4):747-50
references.pmid: 19671588
references.citation: Medicina (B Aires). 1999;59 Suppl 2:147-65
references.pmid: 10668258
references.citation: Exp Parasitol. 2011 Feb;127(2):429-35
references.pmid: 20971106
references.citation: Free Radic Res. 2000 Mar;32(3):245-53
references.pmid: 10730823
references.citation: Antimicrob Agents Chemother. 2011 Oct;55(10):4765-73
references.pmid: 21807972
references.citation: Acta Trop. 2010 Jul-Aug;115(1-2):5-13
references.pmid: 20382097
references.citation: Clin Infect Dis. 1993 Feb;16(2):255-9
references.pmid: 8382964
references.citation: Bioelectrochemistry. 2003 Apr;59(1-2):85-7
references.pmid: 12699823
references.citation: Eur J Med Chem. 2004 Jul;39(7):639-45
references.pmid: 15236845
references.citation: Antimicrob Agents Chemother. 1994 Sep;38(9):1890-8
references.pmid: 7810995
references.citation: Expert Rev Mol Med. 2010 Sep 15;12:e29
references.pmid: 20840799
references.citation: Science. 2005 Jul 15;309(5733):473-6
references.pmid: 16020736
references.citation: Open Med Chem J. 2011;5:21-30
references.pmid: 21629508
references.citation: J Proteomics. 2010 Nov 10;73(12):2306-15
references.pmid: 20621210
references.citation: Biochem J. 1978 Nov 1;175(2):431-9
references.pmid: 217340
references.citation: Cardiovasc Res. 2003 Oct 15;60(1):96-107
references.pmid: 14522411
references.citation: Mem Inst Oswaldo Cruz. 2009 Jul;104(4):549-54
references.pmid: 19722074
references.citation: Bioorg Med Chem Lett. 2003 Jun 16;13(12):2065-9
references.pmid: 12781196
references.citation: Arzneimittelforschung. 1997 Jan;47(1):74-9
references.pmid: 9037448
references.citation: Curr Drug Metab. 2002 Aug;3(4):425-38
references.pmid: 12093358
references.citation: Diagn Microbiol Infect Dis. 2008 Jan;60(1):25-32
references.pmid: 17889480
references.citation: Ann Trop Med Parasitol. 1978 Dec;72(6):523-31
references.pmid: 367298
references.citation: Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:93-6
references.pmid: 15962104
references.citation: J Biol Chem. 1995 Nov 24;270(47):28153-7
references.pmid: 7499305
references.citation: Microbios. 1994;78(315):83-90
references.pmid: 8047025
references.citation: Free Radic Biol Med. 2009 Sep 1;47(5):644-53
references.pmid: 19501647
references.citation: Bioorg Med Chem. 2008 May 1;16(9):5030-8
references.pmid: 18378461
references.citation: Mem Inst Oswaldo Cruz. 2002 Jan;97(1):3-24
references.pmid: 11992141
references.citation: J Ethnopharmacol. 1983 Jul;8(1):97-111
references.pmid: 6632939
references.citation: J Proteome Res. 2008 Jun;7(6):2357-67
references.pmid: 18435557
references.citation: Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:263-9
references.pmid: 19753483
references.citation: Bioorg Med Chem. 2010 May 1;18(9):3224-30
references.pmid: 20378360
references.citation: Proteomics. 2008 Jul;8(13):2735-49
references.pmid: 18546153
references.citation: Mol Pharmacol. 2001 Mar;59(3):586-92
references.pmid: 11179454
references.citation: Arch Biochem Biophys. 1985 Jul;240(1):273-80
references.pmid: 2409922
references.citation: Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:301-10
references.pmid: 19753489
references.citation: Biochem Pharmacol. 1996 Dec 24;52(12):1875-82
references.pmid: 8951346
references.citation: Curr Med Chem Anticancer Agents. 2005 Jul;5(4):389-408
references.pmid: 16101490
references.citation: Mem Inst Oswaldo Cruz. 2010 Mar;105(2):233-8
references.pmid: 20428688
references.citation: Parasitology. 2010 Feb;137(2):251-9
references.pmid: 19765349
references.citation: Antimicrob Agents Chemother. 1996 Mar;40(3):613-5
references.pmid: 8851580
references.citation: Expert Rev Anti Infect Ther. 2007 Aug;5(4):717-26
references.pmid: 17678432
references.citation: Nat Rev Drug Discov. 2006 Nov;5(11):941-55
references.pmid: 17080030
references.citation: Arzneimittelforschung. 2000 Dec;50(12):1120-8
references.pmid: 11190779
references.citation: Annu Rev Microbiol. 1995;49:117-43
references.pmid: 8561456
references.citation: Arch Biochem Biophys. 1978 Mar;186(2):292-7
references.pmid: 205176
references.citation: Antimicrob Agents Chemother. 2010 Jun;54(6):2507-16
references.pmid: 20368397
references.citation: Planta Med. 1996 Apr;62(2):98-105
references.pmid: 8657759
references.citation: Acta Trop. 2010 Jul-Aug;115(1-2):44-54
references.pmid: 20227378
references.citation: J Antimicrob Chemother. 2005 Dec;56(6):1034-41
references.pmid: 16269551
references.citation: J Med Chem. 2008 Jul 24;51(14):4104-14
references.pmid: 18570370
references.citation: Br J Pharmacol. 2010 May;160(2):270-82
references.pmid: 20128813
references.citation: Parasitol Today. 1993 Feb;9(2):66-8
references.pmid: 15463712
references.citation: Rev Inst Med Trop Sao Paulo. 2008 Mar-Apr;50(2):67-74
references.pmid: 18488083
references.citation: Exp Parasitol. 2009 Sep;123(1):73-80
references.pmid: 19520077
references.citation: Curr Med Chem. 2009;16(25):3286-93
references.pmid: 19548870
references.citation: Curr Mol Pharmacol. 2008 Jun;1(2):151-61
references.pmid: 20021429
references.citation: Lancet. 2010 Apr 17;375(9723):1388-402
references.pmid: 20399979
references.citation: Toxicol Appl Pharmacol. 1992 Jan;112(1):2-16
references.pmid: 1733045
references.citation: Antimicrob Agents Chemother. 2008 Sep;52(9):3307-14
references.pmid: 18625779
references.citation: Mem Inst Oswaldo Cruz. 1993 Oct-Dec;88(4):517-28
references.pmid: 8139463
references.citation: Parasitol Res. 2007 Sep;101(4):895-905
references.pmid: 17546464
references.citation: J Ethnopharmacol. 1987 Dec;21(3):279-95
references.pmid: 3441137
references.citation: J Appl Toxicol. 2007 May-Jun;27(3):262-9
references.pmid: 17265417
references.citation: J Antimicrob Chemother. 1992 Dec;30(6):827-32
references.pmid: 1289357
references.citation: Drug Target Insights. 2007;2:61-9
references.pmid: 21901063
references.citation: Curr Med Chem. 2006;13(1):65-85
references.pmid: 16457640
references.citation: Acta Trop. 1978 Mar;35(1):35-40
references.pmid: 24995
references.citation: J Med Chem. 2006 Feb 9;49(3):892-9
references.pmid: 16451055
references.citation: Exp Parasitol. 1977 Jun;42(1):142-9
references.pmid: 324785
references.citation: Curr Opin Investig Drugs. 2006 Feb;7(2):147-57
references.pmid: 16499285
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 5;812(1-2):259-75
references.pmid: 15556503
references.citation: J Parasitol. 2008 Jun;94(3):743-9
references.pmid: 18605790
references.citation: Int J Parasitol. 2004 Jul;34(8):881-6
references.pmid: 15217726
references.citation: Pharmacol Ther. 1987;35(1-2):57-162
references.pmid: 3321102
references.citation: Rev Inst Antibiot (Recife). 1968 Dec;8(1):89-94
references.pmid: 5761014
references.citation: Biochem Pharmacol. 2007 Jun 15;73(12):1939-46
references.pmid: 17462605
references.citation: Trends Parasitol. 2003 May;19(5):232-9
references.pmid: 12763430
references.citation: Curr Med Chem. 2010;17(5):423-52
references.pmid: 20015038
references.citation: Antimicrob Agents Chemother. 2006 Jun;50(6):2185-91
references.pmid: 16723581
references.citation: Cad Saude Publica. 2007;23 Suppl 1:S13-22
references.pmid: 17308713
references.citation: J Antimicrob Chemother. 2004 Feb;53(2):158-66
references.pmid: 14729756
references.citation: Expert Opin Investig Drugs. 2005 Aug;14(8):957-72
references.pmid: 16050790
references.citation: JAMA. 2008 Mar 12;299(10):1134; author reply 1134-5
references.pmid: 18334687
references.citation: Eur J Med Chem. 2008 Aug;43(8):1774-80
references.pmid: 18045742
references.citation: Molecules. 2009 Nov 10;14(11):4570-90
references.pmid: 19924086
references.citation: Qual Life Res. 2011 Feb;20(1):133-8
references.pmid: 21046258
references.citation: Ann Trop Med Parasitol. 2005 Dec;99(8):733-41
references.pmid: 16297286
references.citation: Mem Inst Oswaldo Cruz. 2010 May;105(3):239-45
references.pmid: 20512235
references.citation: Parasitology. 2009 Apr;136(5):499-510
references.pmid: 19281638
references.citation: Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:181-6
references.pmid: 19753473
references.citation: Mem Inst Oswaldo Cruz. 2007 Oct 30;102 Suppl 1:113-22
references.pmid: 17992371
references.citation: Am J Trop Med Hyg. 2010 Apr;82(4):583-7
references.pmid: 20348503
references.citation: Clin Microbiol Rev. 2001 Oct;14(4):659-88, table of contents
references.pmid: 11585780
references.citation: Antimicrob Agents Chemother. 2010 Jul;54(7):2940-52
references.pmid: 20457822
references.citation: Expert Opin Ther Targets. 2009 Jan;13(1):105-21
references.pmid: 19063710
references.citation: Antimicrob Agents Chemother. 2007 Nov;51(11):3803-9
references.pmid: 17698624
references.citation: Micron. 2009 Feb;40(2):157-68
references.pmid: 18849169
references.citation: Free Radic Biol Med. 2008 Sep 15;45(6):733-42
references.pmid: 18588970
references.citation: Mem Inst Oswaldo Cruz. 1993 Jan-Mar;88(1):149-53
references.pmid: 8246750
references.citation: Vet Parasitol. 2007 Apr 30;145(3-4):207-16
references.pmid: 17298866
references.citation: Curr Opin Infect Dis. 2010 Dec;23(6):609-16
references.pmid: 20885320
references.citation: Lancet. 2003 Nov 1;362(9394):1469-80
references.pmid: 14602444
references.citation: Acta Trop. 2010 Jul-Aug;115(1-2):55-68
references.pmid: 19900395
references.citation: Curr Drug Targets. 2009 Mar;10(3):212-31
references.pmid: 19275558
references.citation: J Med Chem. 2002 May 9;45(10):2112-5
references.pmid: 11985478
references.citation: Ann Intern Med. 2006 May 16;144(10):724-34
references.pmid: 16702588
references.citation: Mem Inst Oswaldo Cruz. 2007 Oct 30;102 Suppl 1:75-85
references.pmid: 17891282
references.citation: Methods Enzymol. 2004;378:67-87
references.pmid: 15038958
references.citation: Acta Trop. 2007 Sep;103(3):172-85
references.pmid: 17655815
references.citation: Antimicrob Agents Chemother. 2007 Aug;51(8):2801-10
references.pmid: 17517831
references.citation: Lancet Infect Dis. 2005 Dec;5(12):763-74
references.pmid: 16310148
references.citation: Expert Rev Anti Infect Ther. 2007 Aug;5(4):727-43
references.pmid: 17678433
references.citation: Eur J Med Chem. 2006 Apr;41(4):526-30
references.pmid: 16500733
references.citation: Rev Soc Bras Med Trop. 2008 Mar-Apr;41(2):193-6
references.pmid: 18545843
references.citation: Chem Biol Interact. 1991;80(1):1-41
references.pmid: 1913977